Patents by Inventor Anuradha V

Anuradha V has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Androgen composition for treating an opthalmic condition
    Patent number: 9119772
    Abstract: The disclosure provides compositions for treating an ocular condition. The composition comprises a physiologically effective amount of an androgen, wherein the composition is suitable for topical administration to an eye. The disclosure further provides methods for treating an ocular condition with the disclosed compositions.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: September 1, 2015
    Assignee: Allergan, Inc.
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani
  • CYCLOSPORIN EMULSIONS
    Publication number: 20150045309
    Abstract: Disclosed herein is a composition comprising cyclosporin A at a concentration between about 0.001% (w/v) and about 1.0% (w/v), a plant oil at a concentration between about 0.01% (w/v) and about 10% (w/v), and macrogol 15 hydroxystearate at a concentration between about 0.01% (w/v) and about 10% (w/v).
    Type: Application
    Filed: October 27, 2014
    Publication date: February 12, 2015
    Inventors: Aileen Morgan, Anuradha V. Gore, Mayssa Attar
  • Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
    Patent number: 8952051
    Abstract: The invention provides ophthalmic formulations containing well-defined substituted gamma lactams. The formulations described herein are useful in treating a variety of ocular diseases related to ocular hypertension, such as for example, glaucoma.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: February 10, 2015
    Assignee: Allergan, Inc.
    Inventors: Anuradha V. Gore, Robert S. Jordan, Ajay Parashar, Chetan Pujara, Richard Graham, Mu-Lan Lee
  • TWO PART FORMULATION SYSTEM FOR OPHTHALMIC DELIVERY
    Publication number: 20140364379
    Abstract: Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.
    Type: Application
    Filed: July 26, 2012
    Publication date: December 11, 2014
    Applicant: Allergan Inc.
    Inventors: Anuradha V. Gore, Sai Shankar, Sukhon Likitiersuang, Chetan P. Pujara, Sesha Neervanna
  • SUSPENSIONS OF CYCLOSPORIN A FORM 2
    Publication number: 20140322335
    Abstract: Disclosed herein are methods of formulating cyclosporin A Form 2.
    Type: Application
    Filed: July 7, 2014
    Publication date: October 30, 2014
    Inventors: Anuradha V. Gore, Prem Swaroop Mohanty, E. Quinn Farnes
  • CRYSTALLINE FORM OF CYCLOSPORINE A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF
    Publication number: 20140315827
    Abstract: The present invention relates generally to crystalline forms of cyclosporine A and particularly to a newly identified form of cyclosporine A. The invention further relates to methods for its preparation and to methods for treating certain ocular disorders.
    Type: Application
    Filed: July 2, 2014
    Publication date: October 23, 2014
    Inventors: Anuradha V. Gore, Thomas K. Karami, Ke Wu, Richard S. Graham, Scott W. Smith
  • NON-IRRITATING TESTOSTERONE EMULSIONS
    Publication number: 20140315872
    Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.
    Type: Application
    Filed: March 17, 2014
    Publication date: October 23, 2014
    Applicant: Allergan, Inc.
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani, Andrea S. Kim, Mayssa Attar, Ronald Bradford, Rhett M. Schiffman
  • MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
    Publication number: 20140287988
    Abstract: Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.
    Type: Application
    Filed: December 9, 2013
    Publication date: September 25, 2014
    Applicant: ALLERGAN, INC.
    Inventors: ANURADHA V. GORE, KEVIN S. WARNER, CHETAN P. PUJARA, RICHARD S. GRAHAM, AJAY P. PARASHAR, MU-LAN LEE, ROBERT S. JORDAN, SUKHON LIKITLERSUANG
  • FIXED DOSE COMBINATION OF BIMATOPROST AND BRIMONIDINE
    Publication number: 20140249153
    Abstract: The present invention is directed to compositions comprising combinations of brimonidine and bimatoprost useful for lowering intraocular pressure in a patient and for the treatment of glaucoma.
    Type: Application
    Filed: July 20, 2012
    Publication date: September 4, 2014
    Applicant: Allergan, Inc.
    Inventors: Richard S. Graham, Chetan P. Pujara, Sesha Neervannan, Anuradha V. Gore, Kevin S. Warner
  • Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof
    Patent number: 8772245
    Abstract: The present invention relates generally to crystalline forms of cyclosporine A and particularly to a newly identified form of cyclosporine A. The invention further relates to methods for its preparation and to methods for treating certain ocular disorders.
    Type: Grant
    Filed: May 25, 2012
    Date of Patent: July 8, 2014
    Assignee: Allergan, Inc.
    Inventors: Anuradha V. Gore, Kiomars Karami, Ke Wu, Richard S. Graham, Scott W. Smith
  • ARTIFICIAL TEARS AND THERAPEUTIC USES
    Publication number: 20140141106
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc.
    Type: Application
    Filed: January 28, 2014
    Publication date: May 22, 2014
    Applicant: ALLERGAN, INC.
    Inventors: ANURADHA V. GORE, ROBERT S. JORDAN, KEVIN KROCK, CHETAN PUJARA
  • OPHTHALMIC COMPOSITIONS COMPRISING POLYVINYL CAPROLACTAM-POLYVINYL ACETATE-POLYETHYLENE GLYCOL GRAFT COPOLYMERS
    Publication number: 20140128329
    Abstract: Compositions and methods related to ophthalmic use of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers and therapeutic uses are described herein.
    Type: Application
    Filed: January 10, 2014
    Publication date: May 8, 2014
    Applicant: Allergan, Inc.
    Inventors: Anuradha V. Gore, Chetan P. Pujara, Richard S. Graham, Melissa Gulmezian, Kristin Prinn, Ramakrishnan Srikumar
  • Artificial tears and therapeutic uses
    Patent number: 8679554
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e. g. olive oil, sesame oil, corn oil etc.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: March 25, 2014
    Assignee: Allergan, Inc.
    Inventors: Anuradha V. Gore, Robert S. Jordan, Kevin Krock, Chetan Pujara
  • Computer system for automatically determining slew rate de-rating values
    Patent number: 8670947
    Abstract: Embodiments of the invention provide a system and method to measure and represent the measured value of a limit in terms of another measurement, such as clock values or cycles of the system. The system can include, for example, a test and measurement instrument such as an oscilloscope. In another embodiment of the present invention, slew rate de-rated values may be automatically determined through the use of configurable lookup tables.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: March 11, 2014
    Assignee: Tektronix, Inc.
    Inventors: G. R. N. Prasanth, Pechluck Pongched, Raghavendran N., Mark L. Guenther, Krishna N. H. Sri, Manisha D. Ajgaonkar, Anuradha V.
  • ARTIFICIAL TEARS AND THERAPEUTIC USES
    Publication number: 20130295206
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e. g. olive oil, sesame oil, corn oil etc.
    Type: Application
    Filed: June 28, 2013
    Publication date: November 7, 2013
    Inventors: ANURADHA V. GORE, ROBERT S. JORDAN, KEVIN KROCK, CHETAN PUJARA
  • Artificial tears and therapeutic uses
    Patent number: 8496976
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc.
    Type: Grant
    Filed: June 3, 2010
    Date of Patent: July 30, 2013
    Assignee: Allergan, Inc.
    Inventors: Anuradha V. Gore, Robert S. Jordan, Kevin Krock, Chetan P. Pujara
  • TWO PART FORMULATION SYSTEM FOR OPTHALMIC DELIVERY
    Publication number: 20130029919
    Abstract: Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.
    Type: Application
    Filed: July 25, 2012
    Publication date: January 31, 2013
    Applicant: ALLERGAN, INC.
    Inventors: Anuradha V. GORE, Sai M. SHANKAR, Sukhon LIKITLERSUANG, Chetan P. PUJARA, Sesha NEERVANNAN
  • CRYSTALLINE FORM OF CYCLOSPORINE A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF
    Publication number: 20130023482
    Abstract: The present invention relates generally to crystalline forms of cyclosporine A and particularly to a newly identified form of cyclosporine A. The invention further relates to methods for its preparation and to methods for treating certain ocular disorders.
    Type: Application
    Filed: May 25, 2012
    Publication date: January 24, 2013
    Inventors: Anuradha V. Gore, Kiomars Karami, Ke Wu, Richard S. Graham, Scott W. Smith
  • FIXED DOSE COMBINATION OF BIMATOPROST AND BRIMONIDINE
    Publication number: 20130023536
    Abstract: The present invention is directed to compositions comprising combinations of brimonidine and bimatoprost useful for lowering intraocular pressure in a patient and for the treatment of glaucoma
    Type: Application
    Filed: July 20, 2012
    Publication date: January 24, 2013
    Inventors: Richard S. Graham, Chetan P. Pujara, Sesha Neervannan, Anuradha V. Gore, Kevin S. Warner
  • Compositions For Enhancing Hair Growth
    Publication number: 20130011354
    Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein emulsions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent a single or double bond which can be in the cis or trans configuration, A, B, Z, X, R1 and R2 are as defined in the specification. Such compositions are used in treating the skin or scalp of a human or non-human animal.
    Type: Application
    Filed: November 9, 2010
    Publication date: January 10, 2013
    Applicant: Allergan, Inc.
    Inventors: Anuradha V. Gore, Kevin S. Warner